IL‐33, a tumour‐derived alarmin, in solid tumour induces eosinophil migration and promotes CCL11‐mediated eosinophil infiltration and degranulation, which in turn leads to tumour cell cytotoxicity and reduced tumour growth. The gene discussed is IL33; the disease is neoplasm.